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Objective: The objective of this study was to test the association between the partial pressure of arterial carbon dioxide and survival to hospital discharge among mechanically ventilated patients diagnosed with sepsis in the emergency department. Design: Retrospective cohort study of a single center trial registry. Setting: Academic medical center. Patients: Mechanically ventilated emergency department patients. Inclusion criteria: age 18 years and older, diagnosed with sepsis in the emergency department, and mechanical ventilation initiated in the emergency department. Interventions: Arterial blood gases obtained after initiation of mechanical ventilation were analyzed. The primary outcome was survival to hospital discharge. We tested the association between partial pressure of arterial carbon dioxide and survival using multivariable logistic regression adjusting for potential confounders. Sensitivity analyses, including propensity score matching were also performed. Measurements and Main Results: Six hundred subjects were included, and 429 (72%) survived to hospital discharge. The median (interquartile range) partial pressure of arterial carbon dioxide was 42 (34-53) mm Hg for the entire cohort and 44 and 39 (31-45) mm Hg among survivors and nonsurvivors, respectively (p < 0.0001 Wilcox rank-sum test). On multivariable analysis, a 1 mm Hg rise in partial pressure of arterial carbon dioxide was associated with a 3% increase in odds of survival (adjusted odds ratio, 1.03; 95% CI, 1.01-1.04) after adjusting for tidal volume and other potential confounders. These results remained significant on all sensitivity analyses. Conclusion: In this sample of mechanically ventilated sepsis patients, we found an association between increasing levels of partial pressure of arterial carbon dioxide and survival to hospital discharge. These findings justify future studies to determine the optimal target partial pressure of arterial carbon dioxide range for mechanically ventilated sepsis patients. (Crit Care Med 2018; 46:e213-e220) Key Words: mechanical ventilation; partial pressure of arterial carbon dioxide; Paco 2 ; sepsis S epsis incidence is increasing, and it continues to have high mortality and costs of care. Sepsis-associated respiratory failure is common (1) and often requires mechanical ventilation in the emergency department (ED) and the ICU. The mortality for mechanically ventilated sepsis patients remains unacceptably high at over 40% (1) . Thus, finding new interventions to improve outcomes in this patient population is of the utmost importance.
Prescribing low tidal volume and limiting inspiratory pressures to prevent ventilator-associated lung injury (VALI) is associated with improved outcomes in mechanically ventilated sepsis patients (2) . However, this strategy can result in elevated levels of partial pressure of arterial carbon dioxide (Paco 2 ) (3, 4). The literature has conflicting assessments of Paco 2 and its effects on clinical outcomes. Elevated Paco 2 (i.e., hypercapnia) has been shown to impair alveolar epithelial and neutrophil function and could in theory suppress immune responses and resistance to bacterial infection (5) (6) (7) (8) . In addition, the acidosis induced by hypercapnia can potentially decrease antibiotic efficacy (9) . A recent secondary analysis of three cohort studies found severe hypercapnia (Paco 2 > 50 mm Hg) to be associated with increased mortality among patients with acute respiratory distress syndrome (ARDS) (10) . Alternatively, hypercapnia can modulate several biologically important mechanisms, which could be beneficial in the setting of sepsis, including provision of anti-inflammatory modulators, mitigation of VALI, and modulation of gene expression, which could be important in sepsis survival (11) (12) (13) (14) (15) . In addition, elevated Paco 2 may inhibit bacterial growth, thus decreasing the overall infectious insult (16) . In an analysis of a heterogeneous group of mechanically ventilated patients without ARDS, our group previously found hypercapnia (Paco 2 > 45 mm Hg) was associated with increased survival (17) . Given these conflicting reports, the effects of Paco 2 on clinical outcomes among sepsis patients remains unclear.
The objective of this study was to test the association between Paco 2 early after the initiation of mechanical ventilation and survival to hospital discharge among patients diagnosed with sepsis-associated respiratory failure requiring mechanical ventilation in the ED.
MATERIALS AND METHODS

Setting
We analyzed an ED registry of patients with acute initiation of mechanical ventilation, at a tertiary academic center ( September 2009 to March 2016) (18) . This registry was compiled as part of the Lung-Protective Ventilation Initiated in the ED (LOV-ED) trial (19) . That investigation was a beforeafter study, which evaluated the effectiveness of an ED-based lung-protective mechanical ventilation protocol on reducing the incidence of pulmonary complications (ARDS and ventilator-associated conditions [VACs] ). This registry was previously used in a secondary analysis to evaluate the relationship between Paco 2 and survival among a heterogeneous group of mechanically ventilated patients (i.e., not specifically patients with sepsis) (17) .
Participants
We included patients enrolled in the LOV-ED trial with initiation of mechanical ventilation in the ED. Inclusion criteria were 1) age 18 years and older; 2) mechanical ventilation via an endotracheal tube; and 3) diagnosis of sepsis (i.e., presumed infection plus two systemic inflammatory response syndrome criteria) (20) . Exclusion criteria were 1) death or discontinuation of mechanical ventilation within 24 hours; 2) chronic mechanical ventilation; 3) presence of a tracheostomy; 4) transfer to another hospital; and 5) presence of ARDS during ED presentation (21) . This study was approved by the institutional review board under waiver of informed consent and is reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology Statement: Guidelines for Reporting Observational Studies (22) .
Procedures
Data on baseline demographics, comorbid conditions, illness severity (i.e., Acute Physiology and Chronic Health Evaluation II [APACHE]), and blood pressure were collected in the ED as part of the primary study. Pertinent treatment variables in the ED were also recorded. The results of cultures drawn for suspected sepsis along with the source of positive cultures were recorded. We recorded the initial arterial blood gas analyses performed after the initiation of mechanical ventilation, as well as the initial mechanical ventilator variables. We also collected ICU ventilation settings twice daily for up to 2 weeks.
Static compliance (mL/cm H 2 O) of the respiratory system (C RS ) was calculated as: tidal volume/(plateau pressure -positive end expiratory pressure [PEEP] ). Driving pressure (cm H 2 O) was calculated as: plateau pressure -PEEP. For purposes of these analyses, the initial measured plateau pressure, C RS , and driving pressure were used. The corrected minute ventilation for a normal Paco 2 (VEcorr) was used as a surrogate for dead space to account for changes in dead space as Paco 2 increases. This correction factor has been similarly reported in previous studies (10, 23) . We calculated VEcorr as: initial minute ventilation × actual Paco 2 /40 mm Hg (10, 23) . All data were exported into Stata/SE 14.1 for Mac, StataCorp LP (College Station, TX) for analysis.
Statistical Analysis
Categorical variables were compared using the chi-square test. Continuous variables were compared using Student t test or Wilcoxon rank-sum test as appropriate based on the distribution of data. Spearman's correlation coefficient (r) was used to assess the relationship between Paco 2 , and VEcorr and pH.
The primary outcome was survival to hospital discharge. To test the relationship between Paco 2 after initiation of mechanical ventilation and survival to hospital discharge, a multivariable logistic regression model was constructed. Paco 2 was entered into the model as a continuous variable. A priori, identification of candidate covariables for inclusion in the model was performed in two steps. First, we included patient characteristics and illness severity that were statistically significant in univariate analysis at p < 0.10. All variables were entered into a model and backward elimination with a criterion of p < 0.05 for retention in the model was used. We then added in ventilator variables with clinically relevant differences that were statistically significant in univariate analysis at p < 0.10. Again backward elimination was used with a criterion of p < 0.05 for retention in the final model. Statistical interactions and collinearity were assessed. Goodness-of-fit of the final model was evaluated with the Hosmer-Lemeshow test. To test if our model was correctly specified, we used the linktest command in Stata. We performed several additional subgroup analyses for the primary outcome using multivariable logistic regression modeling (supplemental material, Supplemental Digital Content 1, http://links.lww.com/CCM/D130).
To test if a threshold effect between Paco 2 and survival existed, Paco 2 was entered into a logistic regression model as a categorical variable using ascending ranges (i.e., < 35, 35-45, 46-55, 56-65, > 65 mm Hg), with 35-45 mm Hg as the reference range. The model was adjusted for variables that were retained in the original model. Given Paco 2 is the function of gas exchange and minute ventilation, we also forced VEcorr and initial minute ventilation into this model. Odds ratios for ascending Paco 2 ranges were graphed, and this graph was visually inspected to assess if there was a threshold signal for survival over the Paco 2 ranges. For all models, robust ses to reduce the risk of type I error was used.
Finally, we performed a sensitivity analysis calculating the average treatment effect for hypercapnia (Paco 2 > 45 mm Hg) compared with normocapnia (Paco 2 , 35-45 mm Hg) using propensity score matching. The propensity that a patient had hypercapnia (i.e., propensity score) was modeled using logistic regression as a function of the covariables. We used covariables, which were included in the original logistic regression model to determine the propensity score. We then performed, nearest neighbor matching (with 0.15 set as the largest absolute difference compatible with a valid match [i.e., caliper width]) on the basis of hypercapnia exposure (yes/no) and the propensity score to calculate the average treatment effect for hypercapnia. We evaluated for covariate imbalance between the hypercapnia and matched normocapnia groups using Rubins' B (the absolute standardized difference of the means of the linear index of the propensity score in the hypercapnia and matched normocapnia groups) and Rubin's R (the ratio of the hypercapnia vs. matched normocapnia variances of the propensity score index). A Rubins' B less than 0.25 and a R between 0.5 and 2 is generally considered sufficiently balanced (24) .
Sample Size Calculation
For multivariable logistic modeling, it is common to assume an event per covariable ratio of 10:1 is necessary to ensure adequate power (25, 26) . Our "event" in this study is nonsurvival to hospital discharge (i.e., the less frequent outcome). Based on the number of patients who did not survive to hospital discharge, we were powered to evaluate 17 covariables in a model.
RESULTS
Six hundred patients met all inclusion and no exclusion criteria. Baseline characteristics of the entire cohort, as well as for survivors and nonsurvivors are shown in Table 1 . The median (interquartile range [IQR]) APACHE II score for the entire cohort was 17 (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . Nonsurvivors were more likely to have a malignancy compared with survivors. Nonsurvivors were also more likely to receive a vasopressor infusion, central venous catheter, or blood product transfusion. Table 2 Seventy-two percentage (429/600) of subjects survived to hospital discharge. Table 3 displays the multivariable logistic regression model with Paco 2 treated as a continuous variable and survival to hospital discharge as the dependent variable. After adjusting for all identified significant confounders, elevated Paco 2 was an independent predictor of survival to hospital discharge (aOR, 1.03; 95% CI, 1.01-1.04; p = 0.001). Thus, for every 1 mm Hg rise in Paco 2 , the odds of survival to hospital discharge increased by 3%. Our final model was found to have good fit (Hosmer-Lemeshow test, p = 0.73) and to be correctly specified (ŷ, p < 0.001; ŷ 2 , p = 0.88). These results remained consistent across multiple subgroup analyses (supplemental material, Supplemental Digital Content 1, http:// links.lww.com/CCM/D130). Two hundred thirty patients were found to have hypercapnia, and 210 subjects had normocapnia. Survival to hospital discharge occurred in 83% versus 68% of patients with hypercapnia versus normocapnia, respectively (p < 0.001). Using propensity score matching, we were able to include 206 subjects in the normocapnia group and 221 in the hypercapnia group and found the average treatment effect for hypercapnia was 0.17 (95% CI, 0.07-0.27, p = 0.001). This suggests that hypercapnia increased the probability of survival to hospital discharge by 17%. The Rubins B was 0.21 and Rubins R was 1.34.
DISCUSSION
In this study, we analyzed 600 mechanically ventilated sepsis patients and tested the association between Paco 2 after initiation of mechanical ventilation and survival to hospital discharge. After adjusting for multiple potential confounders and performing propensity score matching, we found higher Paco 2 levels to be independently associated with survival to hospital discharge in this patient population. Given that elevated Paco 2 can be a marker of minute ventilation, we adjusted our original model for initial tidal volume and adjusted our sensitivity model for initial minute ventilation. When entered into the model with Paco 2 , tidal volume was removed for nonsignificance, suggesting that the association between Paco 2 and survival is independent of the tidal volume. Our findings remained consistent across several sensitivity and subgroup analyses, even when adjusted for other ventilator settings, severity of illness, and lactate acid production. These findings suggest hypercapnia during the initial mechanical ventilation period may be beneficial in patients with severe sepsis.
The effects of Paco 2 among critically ill patients have been unclear. Several studies have suggested a beneficial effect of hypercapnia in the setting of sepsis. Hypercapnia has been demonstrated to attenuate key components of the overamplified inflammatory pathways seen in sepsis, as well as to reduce the severity of lung injury. First, hypercapnia decreases tumor necrosis factor-α and interleukin (IL)-1 production, which contributes to tissue injury in septic patients (11, 27) . Second, hypercapnia attenuates neutrophil activity through lowered intracellular pH (14, 28) . Third, in pulmonary endothelial cells, hypercapnia decreases the DNA-binding activity of nuclear factor (NF)-κB, a regulator of proinflammatory pathways. This decreased binding attenuates IL-8 production, with a corresponding decrease in endothelial cell injury (29) . Fourth, hypercapnia has been demonstrated to reduce endogenous nitric oxide (NO) (15, 30, 31) . Endogenous NO production resulting from high-pressure mechanical ventilation has been demonstrated to be harmful in models of endotoxemia (32) . In addition, hypercapnia suppression of endogenous NO production has been demonstrated to augment hypoxic pulmonary vasoconstriction, resulting in improved ventilationperfusion matching (31) . Finally, hypercapnia can inhibit bacterial growth, thus decreasing the overall infectious insult (16) . In summary, our findings are biologically plausible and congruent with the preclinical data that demonstrate a potential beneficial role to manipulating Paco 2 to improve outcome in septic patients.
Our results differ from previous observational studies of patients with community-acquired pneumonia, which found an association between hypercapnia and in-hospital mortality (33, 34) . However, it is possible that in these previous studies hypercapnia was a marker of increased dead-space (35) (i.e., worse pneumonia) as opposed to the cause of poor outcomes. The strong correlation between Paco 2 and VEcorr in our study suggests that elevated Paco 2 could be a marker for dead space. However, we entered VEcorr into our logistic regression model, as previously described (10) and found when Paco 2 and VEcorr were entered into the model together, VEcorr was not found to be significantly associated with survival (removed from the final model for nonsignificance). This suggests that Paco 2 was associated with survival independent of dead space. A recent secondary analysis of three cohort studies found an association between severe hypercapnia (Paco 2 ≥ 50 mm Hg) and mortality among patients with ARDS after adjusting for VEcorr (10) . Our study excluded patients with ARDS, and it is likely that our cohort was less ill compared with those patients with ARDS upon presentation to the ED. The differences in the relationship between Paco 2 and survival between these two studies may suggest that Paco 2 is associated with worse outcomes in patients who already have a high degree of lung injury and increased dead space (10, 33, 34) , while conferring a beneficial effect on subjects at risk for severe lung injury (14, 15, 36) . In addition, patients with ARDS can have a higher degree of dead space, which may not be completely corrected for by VEcorr.
This study has several limitations. First, this observational cohort study can only describe associations and cannot suggest causal inference. Although we used VEcorr as a marker for dead space, there still remains the possibility that elevated Paco 2 is a marker for dead space and not independently associated with survival. However, given increased dead space has been demonstrated to be associated with mortality in mechanically ventilated patients, the positive association between Paco 2 and dead space is unlikely to confound the association between Paco 2 and survival in a positive direction. In addition, although we used multivariable logistic regression analyses to adjust for multiple potential confounders, there still exists the possibility that an unmeasured Paco 2 -associated confounder drove the observed association between hypercapnia and survival, thus our results must be interpreted with caution. Second, hypercapnia may also reflect a patient population that is less ill and therefore has a higher likelihood to survive. A higher APACHE II score in the hypercapnic group compared with the nonhypercapnic group (median [IQR], 19 [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] vs. 16 [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] , respectively; p < 0.001) suggests that this was not the case. Third, we analyzed the initial Paco 2 after mechanical ventilation as a surrogate for total postintubation Paco 2 exposure similar to methodologies used in previous studies of other disease processes (37, 38) . However, there was no standardization with respect to the time to analysis. While our study is representative of real-world care, it is possible that it does not accurately represent the true Paco 2 exposure (i.e., measurement bias). Finally, although there was no association between initial pH and survival to hospital discharge, we did find a lower pH during ICU stay to be associated with increased in-hospital mortality. Given the interdependence of Paco 2 and pH, any clinical intervention to intentionally maintain an elevation of Paco 2 will lead to a lower pH, possibly negating some (if not all) of the potential benefit. However, we found only a moderate correlation between initial Paco 2 and initial pH with an r 2 = 0.23, suggesting Paco 2 is only responsible for 23% of the variation in pH. As such these findings should be considered hypothesis generating, and further research is warranted to determine the clinical implications of targeting hypercapnia in this patient population.
CONCLUSION
In this cohort study of mechanically ventilated sepsis patients, we found increasing Paco 2 levels are associated with increased survival to hospital discharge. These findings suggest that permissive hypercapnia is safe among patients diagnosed with sepsis in the ED and future clinical investigation into early manipulation of Paco 2 in this patient population is warranted.
